本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Mesoblast Limited

13.28
-0.1700-1.26%
成交量:29.83萬
成交額:398.14萬
市值:16.85億
市盈率:-14.90
高:13.56
開:13.28
低:13.14
收:13.45
資料載入中...

公司資料

公司名字:
Mesoblast Limited
交易所:
NASDAQ
成立時間:
2004
員工人數:
73
公司地址:
55 Collins Street,Level 38,Melbourne,Victoria,Australia
郵編:
3000
傳真:
61 3 9639 6030
簡介:
Mesoblast Limited於2004年6月8日在澳大利亞成立。該公司在開發同種異體細胞藥物方面處於世界領先地位。該公司利用其專有的間充質譜系細胞治療技術平台建立了廣泛的商業產品和後期產品候選產品組合。

董事

名稱
職位
Jane Bell
Chairman of the board
Silviu Itescu
Chief Executive Officer and Director
Eric Rose
Chief Medical Officer and Director
Philip Facchina
Director
Philip Krause
Director
William Burns
Director

股東

名稱
職位
Silviu Itescu
Chief Executive Officer and Director
Andrew Chaponnel
Interim Chief Financial Officer
Eric Rose
Chief Medical Officer and Director
Fiona See
SVP and Head, Translational Research
Geraldine Storton
Head of Regulatory Affairs and Quality Management
Justin Horst
Head of Manufacturing
Michael Schuster
Pharma Partnering
Niva Sivakumar
Joint Company Secretary
Paul Hughes
Joint Company Secretary
Peter Howard
Group General Counsel and Corporate Executive